The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol.

More than half of the scheduled nAMD patients in TAE protocol missed their IVI visits during the RP, which resulted in a delay of their treatments. The delay of IVI treatment in those patients resulted in an increase in OCT disease activity and a decrease in BCVA.